相似文献
1
Directing systemic oncolytic viral delivery to tumors via carrier cells.
Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):119-26. doi: 10.1016/j.cytogfr.2010.02.004. Epub 2010 Mar 11.
2
Mesenchymal Stem Cell-Mediated Delivery of an Oncolytic Adenovirus Enhances Antitumor Efficacy in Hepatocellular Carcinoma.
Cancer Res. 2019 Sep 1;79(17):4503-4514. doi: 10.1158/0008-5472.CAN-18-3900. Epub 2019 Jul 9.
3
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Gene Ther. 2009 Feb;16(2):262-78. doi: 10.1038/gt.2008.165. Epub 2008 Dec 11.
4
Systemic administration of human mesenchymal stromal cells infected with polymer-coated oncolytic adenovirus induces efficient pancreatic tumor homing and infiltration.
J Control Release. 2019 Jul 10;305:75-88. doi: 10.1016/j.jconrel.2019.04.040. Epub 2019 May 6.
5
The discrete charm of oncolytic viruses: Toward the finish line.
Cancer Cell. 2025 Apr 14;43(4):611-618. doi: 10.1016/j.ccell.2025.03.010. Epub 2025 Mar 27.
6
Recent advances in oncolytic virus-based cancer therapy.
Virus Res. 2019 Sep;270:197675. doi: 10.1016/j.virusres.2019.197675. Epub 2019 Jul 25.
7
Mesenchymal stem cells and oncolytic viruses: joining forces against cancer.
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001684.
8
Mesenchymal Stem Cells Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.
Clin Cancer Res. 2021 Mar 15;27(6):1766-1777. doi: 10.1158/1078-0432.CCR-20-1499. Epub 2020 Dec 3.
9
A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.
Mol Pharm. 2011 Oct 3;8(5):1559-72. doi: 10.1021/mp200161f. Epub 2011 Jun 30.
10
Overcoming Barriers in Oncolytic Virotherapy with HDAC Inhibitors and Immune Checkpoint Blockade.
Viruses. 2016 Jan 6;8(1):9. doi: 10.3390/v8010009.
引用本文的文献
1
Oncolytic viruses as cancer therapeutics: From mechanistic insights to clinical translation.
Mol Ther. 2025 May 7;33(5):2217-2228. doi: 10.1016/j.ymthe.2025.03.035. Epub 2025 Mar 25.
2
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis.
J Transl Med. 2024 Nov 5;22(1):1000. doi: 10.1186/s12967-024-05794-4.
3
Mesenchymal Stem Cells in Cancer Therapy.
Adv Exp Med Biol. 2025;1474:149-177. doi: 10.1007/5584_2024_824.
4
The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?
Vaccines (Basel). 2024 Jun 28;12(7):721. doi: 10.3390/vaccines12070721.
5
Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy.
Cancer Immunol Immunother. 2024 Jul 2;73(9):173. doi: 10.1007/s00262-024-03757-8.
6
Enhancement of Therapeutic Potential of Oncolytic Virus with Homologous Tumor Cell Membranes for Pancreatic Cancer.
IET Nanobiotechnol. 2024 Feb 13;2024:9970665. doi: 10.1049/2024/9970665. eCollection 2024.
7
Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner.
Biomark Res. 2024 Mar 25;12(1):36. doi: 10.1186/s40364-024-00581-1.
8
Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment.
Mol Ther Oncolytics. 2022 Sep 17;27:26-47. doi: 10.1016/j.omto.2022.09.004. eCollection 2022 Dec 15.
9
Nanocarriers for cancer nano-immunotherapy.
Drug Deliv Transl Res. 2023 Jul;13(7):1936-1954. doi: 10.1007/s13346-022-01241-3. Epub 2022 Oct 3.
10
Mesenchymal stem/stromal cells in cancer therapy.
J Hematol Oncol. 2021 Nov 17;14(1):195. doi: 10.1186/s13045-021-01208-w.
本文引用的文献
1
Ischemia-induced neurogenesis of neocortical layer 1 progenitor cells.
Nat Neurosci. 2010 Feb;13(2):173-9. doi: 10.1038/nn.2473. Epub 2009 Dec 27.
2
Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies.
PLoS One. 2009 Dec 15;4(12):e8314. doi: 10.1371/journal.pone.0008314.
3
Human bone marrow-derived mesenchymal stem cells for intravascular delivery of oncolytic adenovirus Delta24-RGD to human gliomas.
Cancer Res. 2009 Dec 1;69(23):8932-40. doi: 10.1158/0008-5472.CAN-08-3873. Epub 2009 Nov 17.
4
Adipose-derived stem cells as therapeutic delivery vehicles of an oncolytic virus for glioblastoma.
Mol Ther. 2010 Feb;18(2):377-85. doi: 10.1038/mt.2009.265. Epub 2009 Nov 10.
5
Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.
Mol Ther. 2009 Oct;17(10):1667-76. doi: 10.1038/mt.2009.194. Epub 2009 Aug 18.
6
Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells.
Clin Cancer Res. 2009 Aug 1;15(15):4925-34. doi: 10.1158/1078-0432.CCR-08-3076. Epub 2009 Jul 28.
7
Stem cells for ischemic brain injury: a critical review.
J Comp Neurol. 2009 Jul 1;515(1):125-44. doi: 10.1002/cne.22038.
8
Neural stem cells target intracranial glioma to deliver an oncolytic adenovirus in vivo.
Gene Ther. 2009 Feb;16(2):262-78. doi: 10.1038/gt.2008.165. Epub 2008 Dec 11.
9
Neural stem cell tropism to glioma: critical role of tumor hypoxia.
Mol Cancer Res. 2008 Dec;6(12):1819-29. doi: 10.1158/1541-7786.MCR-08-0146.
10
Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas.
Mol Ther. 2009 Jan;17(1):183-90. doi: 10.1038/mt.2008.229. Epub 2008 Nov 4.
Zotero 插件